Advertisement

Der Onkologe

, Volume 24, Issue 12, pp 952–957 | Cite as

Diagnostik beim nichtkleinzelligen Lungenkarzinom

  • S. Kurz
  • C. GrohéEmail author
Leitthema
  • 131 Downloads

Zusammenfassung

Grundlage für die Behandlung des nichtkleinzelligen Lungenkarzinoms sind eingehende Kenntnisse der zugrunde liegenden Krankheitscharakteristikamerkmale und der verschiedenen Therapieoptionen. Die Ergebnisse der Diagnostik sollten in einer interdisziplinären Tumorkonferenz eingeordnet werden. Die präzise Histologie und die genaue TNM-Klassifikation sind prognoserelevant und führen zu einer individuellen und optimalen Therapie. Der vorliegende Artikel wurde basierend auf nationalen und internationalen Leitlinien sowie auf einer selektiven PubMed-Suche erstellt.

Schlüsselwörter

Prognose Klinische Entscheidungsfindung Molekulare Diagnostik Tumorklassifikation Phänotyp 

Diagnostic procedures in non-small cell lung cancer

Abstract

Profound knowledge of the underlying disease characteristics and the different therapeutic options are the basis for treatment of non-small cell lung cancer (NSCLC). Comprehensive diagnostic procedures enable an exact diagnosis, which should be discussed by an interdisciplinary tumor board. Precise histology and TNM classification are of prognostic relevance and guide optimized individual treatment. The current article is based on national and international guidelines as well as a selective PubMed search.

Keywords

Prognosis Clinical decision making Molecular diagnostic techniques Neoplasm staging Phenotype 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

S. Kurz und C. Grohé geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms Langversion 1.0 – Februar 2018 AWMF-Registernummer: 020/007OLGoogle Scholar
  2. 2.
    Hammerschmidt S, Wirtz H (2009) Lungenkarzinom – aktuelle Diagnostik und Therapie. Dtsch Arztebl Int 106(49):809–820PubMedPubMedCentralGoogle Scholar
  3. 3.
    Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M (2018) NCCN guidelines insights: non small cell lung cancer, version 5.2018. J Natl Compr Canc Netw 16(7):807–821CrossRefGoogle Scholar
  4. 4.
    Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S, ESMO Guidelines Committee (2018) Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Supplement_4):iv192–iv237CrossRefGoogle Scholar
  5. 5.
    van Tinteren H et al (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359(9315):1388–1393CrossRefGoogle Scholar
  6. 6.
    Herder GJ et al (2006) Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 24(12):1800–1806CrossRefGoogle Scholar
  7. 7.
    Birim O et al (2005) Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 79(1):375–382CrossRefGoogle Scholar
  8. 8.
    Dhillon SS, Harris K (2017) Bronchoscopy for the diagnosis of peripheral lung lesions. J Thorac Dis 9(Suppl 10):S1047–S1058.  https://doi.org/10.21037/jtd.2017.05.48 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wang Memoli JS, Nietert PJ, Silvestri GA (2012) Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest 142:385–393.  https://doi.org/10.1378/chest.11-1764 CrossRefPubMedGoogle Scholar
  10. 10.
    Ozturk A, Gullu YT (2018) Excellence in non-small cell lung cancer staging by endobronchial-TBNA: Comparison with PET-CT and surgery. Minim Invasive Ther Allied Technol 27:1–7.  https://doi.org/10.1080/13645706.2018.1513944 CrossRefGoogle Scholar
  11. 11.
    Lilo MT, Allison DB, Younes BK, Cui M, Askin FB, Gabrielson E, Li QK (2017) The critical role of EBUS-TBNA cytology in the staging of mediastinal lymph nodes in lung cancer patients: A correlation study with positron emission tomography findings. Cancer Cytopathol 125(9):717–725.  https://doi.org/10.1002/cncy.21886 CrossRefPubMedGoogle Scholar
  12. 12.
    Ong P, Grosu H, Eapen GA, Rodriguez M, Lazarus D, Ost D, Jimenez CA, Morice R, Bandi V, Tamara L, Cornwell L, Green L, Zhu A, Casal RF (2015) Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography. Ann Am Thorac Soc 12(3):415–419.  https://doi.org/10.1513/AnnalsATS.201409-429OC CrossRefPubMedGoogle Scholar
  13. 13.
    Bolliger CT (2009) Functional reserve before lung resection: how low can we go? Respiration 78(1):20–22CrossRefGoogle Scholar
  14. 14.
    Varela G et al (2001) Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection. Eur J Cardiothorac Surg 19(3):351–354CrossRefGoogle Scholar
  15. 15.
    Ohno Y et al (2007) Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol 189(2):400–408CrossRefGoogle Scholar
  16. 16.
    Koul R, Rathod S, Dubey A, Bashir B, Chowdhury A (2018) Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment. Lung Cancer 123:116–120.  https://doi.org/10.1016/j.lungcan.2018.06.029 CrossRefPubMedGoogle Scholar
  17. 17.
    Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions (2017) The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol 12(7):1109–1121.  https://doi.org/10.1016/j.jtho.2017.04.011 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für PneumologieEvangelische Lungenklinik BerlinBerlinDeutschland

Personalised recommendations